Summary:
This study is being done to learn more about
whether 1-dose of the FDA-approved HPV vaccine produces the same immune
response as 2- or 3- doses of HPV vaccination. We will use this knowledge to
inform public health decisions about broader use of 1-dose HPV vaccination.
Qualified Participants Must:
• Be between the ages 18-45
• NOT have received HPV vaccination
Qualified Participants May Receive:
- Up
to 3 doses of HPV vaccine (Gardasil 9)
- 3 Fine Needle Aspirations (FNAs) of the lymph nodes
- 2 Bone Marrow Aspirations (BMAs)
- Up to $2,465 - $2,890 for completing all study procedures including 14-17 clinic visits with blood draws over 66 months